Previous close | 21.94 |
Open | 21.44 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1100 |
Day's range | 20.27 - 21.69 |
52-week range | 12.05 - 34.98 |
Volume | |
Avg. volume | 498,962 |
Market cap | 1.154B |
Beta (5Y monthly) | 0.92 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ALL-REMOTE COMPANY/WILMINGTON, Del., March 19, 2024--Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company’s new Chief Technology Officer.
WILMINGTON, Del., March 14, 2024--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024.
WILMINGTON, Del., February 27, 2024--Phreesia announces that its Chief Clinical Officer Hilary Hatch, PhD, has been selected to participate in NQF's 2024-2025 Leadership Consortium.